In his early career, he studied membrane proteins using all-atom molecular dynamics (MD) simulations with the CHARMM and NAMD programs, focusing on a wide range of membrane systems from a membrane-bound small peptide to a large complex of ion channels in various bilayer systems
A Personalized Approach to Treatment While standard semaglutide protocols show meaningful results for many patients, a personalized approach may help optimize outcomes beyond one-size-fits-all dosing
According to a systematic review by Cochrane, semaglutide produces clinically significant weight loss compared to placebo , with most side effects being mild to moderate in severity
Secondary analysis of multiple general population studies, including AMPLITUDE-O, SELECT, ELIXA, SURPASS, and LEADER, demonstrated significant improvements in various surrogate kidney outcomes, including slowing eGFR decline, proteinuria reduction, and decreased progression to end-stage renal disease